Skip to main content
Tuoxin Pharmaceutical Group Co.,Ltd. logo

Tuoxin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 301089 ISIN · CNE100004YC3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 734 across all filing types
Latest filing 2023-01-10 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 301089

About Tuoxin Pharmaceutical Group Co.,Ltd.

https://www.tuoxinpharm.com

Tuoxin Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and distribution of nucleosides and nucleotides. The company serves as a major global supplier of active pharmaceutical ingredients (APIs) and chemical intermediates. Its core product portfolio includes cytidine, inosine, guanosine, adenosine, and their various derivatives, which are essential components in the synthesis of antiviral, anti-tumor, and cardiovascular medications. Notably, the group provides key intermediates for drugs such as Ribavirin and Azvudine. Tuoxin Pharmaceutical leverages advanced synthetic biotechnology and large-scale manufacturing capabilities to support the global pharmaceutical industry. The company maintains a focus on technological innovation and quality control to ensure the stability and purity of its chemical products for diverse therapeutic applications.

Recent filings

Filing Released Lang Actions
关于持股5%以上股东减持时间过半的进展公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the progress of shareholding reduction by shareholders holding more than 5% of the company's shares. It details the number of shares reduced, the dates, prices, and compliance with relevant laws and regulations. It does not contain financial statements or performance data, nor is it a report or presentation. It is a regulatory announcement about a major shareholding change, specifically a reduction in shareholding by significant shareholders. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length is short and focused on shareholding changes, confirming this classification.
2023-01-10 Chinese
关于子公司完成工商变更登记并换发营业执照的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding a subsidiary completing a business registration change and obtaining a new business license. It contains no financial data, no report or financial results, and is not a meeting or voting announcement. It is a regulatory announcement about corporate administrative changes. The document length is short (697 characters) and it is an announcement of a completed registration event, not a report or financial filing. Therefore, it fits best under Regulatory Filings (RNS).
2023-01-06 Chinese
关于对外投资设立子公司新乡市核苷产业研究院有限公司的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company about its decision to invest in and establish a wholly owned subsidiary. It includes details about the investment, the new subsidiary, the purpose, risks, and impact on the company. It references a board meeting resolution approving the investment. The document is relatively short (1491 characters) and does not contain financial statements or detailed financial data. It is an announcement of a corporate action (investment in a subsidiary) rather than a financial report or regulatory filing. This fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including investments and establishment of subsidiaries.
2023-01-04 Chinese
第四届董事会第十九次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 19th meeting of the 4th Board of Directors of Xinxiang Tuoxin Pharmaceutical Co., Ltd. It details the meeting's convening, attendance, and the approval of an investment proposal to establish a subsidiary. There is no financial data, earnings information, or report publication mentioned. The content focuses on board decisions and meeting outcomes, which aligns with Board/Management Information filings. The document length is short and it is not a report or announcement of a report publication, so it is not an RPA or 10-K. Therefore, the appropriate classification is MANG (Board/Management Information).
2023-01-04 Chinese
关于使用部分闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the use of idle raised funds for cash management, detailing the investment products, risk analysis, and control measures. It does not contain financial statements or comprehensive financial data but rather provides an update on the company's financing activities related to the use of raised funds. The document length is short (1975 characters) and focuses on a specific financing-related activity rather than a full report or regulatory filing. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2022-12-29 Chinese
关于使用部分闲置募集资金进行现金管理到期赎回的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company about the use of idle raised funds for cash management and the maturity redemption of related financial products. It details specific transactions, amounts, dates, and returns on these investments. The document is relatively short (1770 characters) and focuses on the company's cash management activities related to idle raised funds, including the maturity and redemption of structured deposits and other financial products. It does not contain comprehensive financial statements or detailed financial performance data. It is not an annual or interim report, nor an earnings release. It is not a regulatory filing or certification. The content fits best with a Capital/Financing Update (CAP) as it relates to the management and use of raised capital funds and their investment returns.
2022-12-23 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.